Immunitybio Inc (IBRX) Financials

$8.08

$-0.12 (-1.40%)

As on 04-Sep-2026 13:37EDT

Market cap

$8,532 Mln

Revenue (TTM)

$166 Mln

P/E Ratio

--

P/B Ratio

0

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	165.79	113.29	14.75	0.62	0.24	0.93
Cost of Revenue	8.91	0.75	17.55	18.51	24.19	--
Gross Profit	156.88	112.54	14.75	0.62	0.24	0.93
Operating Expenses	408.68	368.56	358.93	362.87	351.54	331.21
Operating Profit (EBIT)	-251.80	-256.03	-344.18	-362.25	-351.30	-330.28
Other Income	--	--	--	--	-2.47	-4.71
Profit before Tax	-992.58	-351.61	-413.65	-583.89	-417.29	-349.84
Provision for Tax	-0.18	-0.14	0.08	-0.04	0.03	0.01
Profit after Tax (Net Income)	-992.36	-351.40	-413.56	-583.20	-416.57	-346.79
Minority Interest	0.06	0.07	0.08	0.75	-0.75	-3.06
Consolidated Profit	--	--	--	--	-416.57	-346.79

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	-1,046.63	-499.57	-489.10	-586.99	-447.33	-242.17
Minority Interest	0.06	--	--	--	-2.49	-1.74
Non-Current Liabilities	1,597.54	939.72	816.12	1,032.11	311.32	343.83
Current Liabilities	76.73	61.75	54.94	58.28	500.86	369.00
Total Liabilities	705.23	501.90	382.93	504.45	362.36	468.91

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	189.52	187.02	198.35	210.37	221.78	134.56
Current Assets	438.98	314.88	184.59	294.08	140.58	334.35
Total Assets	705.23	501.90	382.93	504.45	362.36	468.91
Total Debt*	813.06	878.12	504.17	726.72	723.77	645.66
Net Current Assets	362.25	253.12	129.64	235.80	-360.28	-34.65

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-304.94	-391.24	-366.76	-337.51	-274.42
Cash Flow from Investing Activities	--	-149.80	-12.25	-30.47	27.30	-84.89
Cash from Financing Activities	--	400.24	281.63	558.34	233.61	505.44
Net Cash Inflow / Outflow	--	--	--	--	-76.60	146.14

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-0.97	-0.36	-0.56	-0.99	-1.03	-0.87
Cash EPS ($)	--	-0.34	-0.54	-0.95	-0.99	-0.84
Adjusted Book Value ($)	--	--	--	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.31	-0.53	-0.62	-0.84	-0.69
Free Cash Flow per Share ($)	--	-0.31	-0.54	-0.67	-1.03	-0.78

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-178.55	-534.31	-280.26	-122.53	-124.02
ROE (%)	--	71.08	76.86	112.77	120.83	191.61
ROA (%)	-171.40	-79.43	-93.21	-134.56	-100.22	-100.48
EBIT Margin (%)	-548.47	-211.04	-1,912.42	-79,931.67	-154,225.42	-35,866.17
Net Margin (%)	-598.56	-310.18	-2,804.77	-93,761.41	18,655.04	9,184.06
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	192.92	6.68	22.71	1.59	-0.74	0.54
EBIT Growth (%)	-257.67	15.22	43.28	-34.32	-10.49	-54.40
Net Profit Growth (%)	-170.37	15.03	29.09	-40.00	-20.12	-56.32
EPS Growth (%)	-110.92	0.37	0.43	0.04	-0.18	-0.51
Book Value Growth (%)	-55.11	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-5.58	-4.55	-5.08	-4.91	-6.96
Price / Book Value	--	-3.92	-3.84	-5.05	-4.57	-9.97
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-8.99	-11.61	-8.45	-7.16	-7.57	-8.55
Close Price ($)	8.76	1.98	2.56	5.02	5.07	6.08
High Price ($)	12.43	4.27	10.53	6.93	7.85	45.42
Low Price ($)	1.95	1.83	2.50	1.21	2.60	5.11
Market Cap ($ Cr)	8,531.68	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	-0.74	-1.76	-1.03	-1.24	-1.62	-2.67
Short term debt to equity ratio	-0.01	-0.02	-0.02	-0.01	-0.97	-1.25
Current Ratio	5.72	5.10	3.36	5.05	0.28	0.91
Quick Ratio	5.70	5.08	3.21	5.05	0.23	--
Interest Coverage	-10.92	-2.12	-2.14	-5.73	-7.85	-22.56

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	32.25	37.62	17.99	509.32	787.50	142.72
Asset Turnover	0.29	0.26	0.03	0.00	0.00	0.00
Receivable days	--	72.98	72.10	1,485.08	2,452.50	652.29
Inventory Days	--	2,226.91	86.06	259.99	397.89	--
Payable days	--	3,323.39	165.63	298.04	244.84	--
Cash Conversion Cycle	--	-1,023.50	-7.47	1,447.03	2,605.55	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.